Key result
Moderate-to-severe mitral regurgitation was associated with a lower rate of favorable clinical outcome after EVT compared to non-significant MR (11% vs 26%; OR 0.14; 95% CI 0.02-0.84; p=0.031).
Why the study?
Some hyperacute stroke patients experience unfavorable outcomes after EVT despite successful recanalization, leading to the hypothesis that moderate-to-severe MR might reduce favorable clinical outcomes in patients with AF.
Does moderate-to-severe mitral regurgitation reduce the rate of favorable clinical outcomes after endovascular thrombectomy in stroke patients with atrial fibrillation?
Cohort (n=127)
Does moderate-to-severe mitral regurgitation reduce the rate of favorable clinical outcomes after endovascular thrombectomy in stroke patients with atrial fibrillation?
Moderate-to-severe mitral regurgitation is associated with a significantly lower likelihood of favorable clinical recovery at 3 months in atrial fibrillation patients undergoing endovascular thrombectomy for stroke.
Answers are grounded in this paper and cite their sources.
Moderate-to-severe MR warrants caution during EVT planning in AF stroke; leaves open whether MR modification alters recovery.
OBJECTIVE: Some hyperacute stroke patients have unfavorable outcomes after endovascular thrombectomy (EVT) despite successful recanalization. We hypothesized that a cardiac parameter, moderate-to-severe mitral regurgitation (MR), might decrease the rate of favorable clinical outcome after EVT in patients with atrial fibrillation (AF). METHOD: From our prospective EVT registry, AF patients who underwent transthoracic echocardiography (TTE) were retrospectively analyzed. Based on the presence of moderate-to-severe MR, patients were assigned to either significant MR or nonsignificant MR group. The severity of MR was determined by the ratio of the color Doppler jet area to the left atrial area in mid-systole. Moderate-to-severe MR was estimated to be at a ratio of >20%. Favorable outcome was defined as having a modified Rankin Scale score of 0-1 at 3 months. RESULT: 127 patients with AF who underwent TTE were included in the study. TTE results found that 25 (20%) patients had significant MR. Patients with significant MR were older (p = 0.051) and had enlarged left (p = 0.015) and right (p = 0.002) atria. Tricuspid and aortic regurgitation (p = 0.007 and 0.043, respectively) were more severe in significant MR group. At 3 months, favorable outcomes were 11% in the significant MR group and 26% in the non-significant MR group (p = 0.031). Multivariate regression analysis reported that moderate-to-severe MR was a negative predictor of favorable outcome (odds ratio = 0.14; 95% confidence interval = 0.02, 0.84; p = 0.031). CONCLUSIONS: Significant MR might prevent the clinical recovery of AF patients.
No takes yet. Share an insight, caveat, or question.
Aoki et al. (2020) conducted a cohort in Stroke with atrial fibrillation (n=127). Moderate-to-severe mitral regurgitation vs. Non-significant mitral regurgitation was evaluated on Favorable outcome (modified Rankin Scale score of 0-1 at 3 months) (OR 0.14, 95% CI 0.02, 0.84, p=0.031). Moderate-to-severe mitral regurgitation was associated with a lower rate of favorable clinical outcome after EVT compared to non-significant MR (11% vs 26%; OR 0.14; 95% CI 0.02-0.84; p=0.031).
Synapse has enriched 10 related papers. Consider them for comparative context: